Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
Eur Rev Med Pharmacol Sci
; 21(2 Suppl): 102-107, 2017 06.
Article
in En
| MEDLINE
| ID: mdl-28724171
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Inflammatory Bowel Diseases
/
Irritable Bowel Syndrome
/
Beta-Glucans
/
Enzyme Therapy
/
Inositol
Type of study:
Clinical_trials
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
FARMACOLOGIA
/
TOXICOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Italy